Autonomic imbalance: prophet of doom or scope for hope?

Diabet. Med. 28, 643–651 (2011)

[1]  T. Yeh,et al.  Altered cardiac autonomic function may precede insulin resistance in metabolic syndrome. , 2010, The American journal of medicine.

[2]  F. Zitman,et al.  Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities. , 2010, The Journal of clinical endocrinology and metabolism.

[3]  K. Ondičová,et al.  Multilevel interactions between the sympathetic and parasympathetic nervous systems: a minireview. , 2010, Endocrine regulations.

[4]  J. Fleg,et al.  Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial , 2010, Diabetes Care.

[5]  J. Stradling,et al.  Continuous positive airway pressure treatment for obstructive sleep apnoea reduces resting heart rate but does not affect dysrhythmias: a randomised controlled trial , 2009, Journal of sleep research.

[6]  D. Giugliano,et al.  Long-term glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes. , 2009, The Journal of clinical endocrinology and metabolism.

[7]  G. Nijpels,et al.  Microalbuminuria and Cardiovascular Autonomic Dysfunction Are Independently Associated With Cardiovascular Mortality: Evidence for Distinct Pathways , 2009, Diabetes Care.

[8]  J. Albers,et al.  Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) , 2009, Circulation.

[9]  A. Ferguson,et al.  Adiponectin acts in the nucleus of the solitary tract to decrease blood pressure by modulating the excitability of neuropeptide Y neurons , 2009, Brain Research.

[10]  R. Pop-Busui,et al.  Effects of cyclooxygenase-2 gene inactivation on cardiac autonomic and left ventricular function in experimental diabetes. , 2009, American journal of physiology. Heart and circulatory physiology.

[11]  A. Diedrich,et al.  Diabetic Hypertensive Leptin Receptor–Deficient db/db Mice Develop Cardioregulatory Autonomic Dysfunction , 2009, Hypertension.

[12]  A. Ferguson,et al.  Adiponectin depolarizes parvocellular paraventricular nucleus neurons controlling neuroendocrine and autonomic function. , 2009, Endocrinology.

[13]  R. Freeman,et al.  Antecedent Hypoglycemia Impairs Autonomic Cardiovascular Function , 2009, Diabetes.

[14]  Grant D. Huang,et al.  Glucose control and vascular complications in veterans with type 2 diabetes. , 2009, The New England journal of medicine.

[15]  R. Holle,et al.  Subclinical Inflammation and Diabetic Polyneuropathy , 2009, Diabetes Care.

[16]  Viola Vaccarino,et al.  Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men. , 2008, American heart journal.

[17]  J. Grässler,et al.  Nitrosylated Proteins in Monocytes as a new Marker of Oxidative-Nitrosative Stress in Diabetic Subjects with Macroangiopathy , 2008, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[18]  J. Tuomilehto,et al.  Sleep duration is associated with an increased risk for the prevalence of type 2 diabetes in middle-aged women - The FIN-D2D survey. , 2008, Sleep medicine.

[19]  W. Rathmann,et al.  Prediction of Mortality Using Measures of Cardiac Autonomic Dysfunction in the Diabetic and Nondiabetic Population , 2008, Diabetes Care.

[20]  E. Tasali,et al.  Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. , 2008, Proceedings of the American Thoracic Society.

[21]  O. Pedersen,et al.  Effect of a multifactorial intervention on mortality in type 2 diabetes. , 2008, The New England journal of medicine.

[22]  K. Hermayer,et al.  Current concepts in targeted therapies for the pathophysiology of diabetic microvascular complications , 2007, Vascular health and risk management.

[23]  J. Groves,et al.  Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats. , 2007, American journal of physiology. Endocrinology and metabolism.

[24]  Chih-Hsing Wu,et al.  Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose. , 2007, The Journal of clinical endocrinology and metabolism.

[25]  A. Oto,et al.  Increased myocardial vulnerability and autonomic nervous system imbalance in obstructive sleep apnea syndrome. , 2007, Respiratory medicine.

[26]  G. Rodriguez,et al.  Alterations in the autonomic control of heart rate variability in patients with anorexia or bulimia nervosa: Correlations between sympathovagal activity, clinical features, and leptin levels , 2007, Journal of endocrinological investigation.

[27]  S. Redolfi,et al.  Autonomic Neuropathy Increases the Risk of Obstructive Sleep Apnea in Obese Diabetics , 2007, Respiration.

[28]  M. Matsuda,et al.  Effects of Adiponectin on the Renal Sympathetic Nerve Activity and Blood Pressure in Rats , 2007, Experimental biology and medicine.

[29]  Aaron I. Vinik,et al.  Autonomic function in sleep apnea patients: increased heart rate variability except during REM sleep in obese patients , 2007, Sleep and Breathing.

[30]  A. Vinik,et al.  Diabetic Cardiovascular Autonomic Neuropathy , 2007, Circulation.

[31]  J. Stradling,et al.  Prevalence of obstructive sleep apnoea in men with type 2 diabetes , 2006, Thorax.

[32]  A. Vinik,et al.  The role of PPARs in the microvascular dysfunction in diabetes. , 2006, Vascular pharmacology.

[33]  H. Sasano,et al.  Cold Exposure Suppresses Serum Adiponectin Levels through Sympathetic Nerve Activation in Mice , 2006, Obesity.

[34]  A. Vinik,et al.  Pathophysiology and treatment of diabetic peripheral neuropathy: the case for diabetic neurovascular function as an essential component. , 2006, Current diabetes reviews.

[35]  W. Rathmann,et al.  Selective contribution of diabetes and other cardiovascular risk factors to cardiac autonomic dysfunction in the general population. , 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[36]  F. Wilhelm,et al.  Effects of lifestyle modification on the progression of coronary atherosclerosis, autonomic function, and angina--the role of GNB3 C825T polymorphism. , 2006, American heart journal.

[37]  Mark E Molitch,et al.  The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. , 2006, Diabetes care.

[38]  R. Townsend,et al.  Prolonged (48-hour) modest hyperinsulinemia decreases nocturnal heart rate variability and attenuates the nocturnal decrease in blood pressure in lean, normotensive humans. , 2006, The Journal of clinical endocrinology and metabolism.

[39]  Masahiko Motooka,et al.  RESEARCH Effect , 2022 .

[40]  S. Heymsfield,et al.  Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. , 2005, The Journal of clinical investigation.

[41]  V. Somers,et al.  Day-night pattern of sudden death in obstructive sleep apnea. , 2005, The New England journal of medicine.

[42]  Jose M Marin,et al.  Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study , 2005, The Lancet.

[43]  A. Vinik,et al.  Metabolic memory in diabetes–focus on insulin , 2005, Diabetes/metabolism research and reviews.

[44]  Y. Aso,et al.  Adiponectin concentrations in sera from patients with type 2 diabetes are negatively associated with sympathovagal balance as evaluated by power spectral analysis of heart rate variation. , 2004, Diabetes care.

[45]  D. Ziegler,et al.  Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy. , 2004, Diabetes care.

[46]  D. Giugliano,et al.  Effect of irbesartan on nitrotyrosine generation in non-hypertensive diabetic patients , 2004, Diabetologia.

[47]  D. Jacobs,et al.  Influence of autonomic nervous system dysfunction on the development of type 2 diabetes: the CARDIA study. , 2003, Diabetes care.

[48]  P. Bottini,et al.  Sleep-disordered breathing in nonobese diabetic subjects with autonomic neuropathy , 2003, European Respiratory Journal.

[49]  T. Ogihara,et al.  Serum Uric Acid and Plasma Norepinephrine Concentrations Predict Subsequent Weight Gain and Blood Pressure Elevation , 2003, Hypertension.

[50]  Braxton D Mitchell,et al.  The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. , 2003, Diabetes care.

[51]  É. Szabó,et al.  Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. , 2003, Toxicology letters.

[52]  D. Swain,et al.  Use of heart rate reserve and rating of perceived exertion to prescribe exercise intensity in diabetic autonomic neuropathy. , 2003, Diabetes care.

[53]  V. Somers,et al.  Sympathetic nerve activity in obstructive sleep apnoea. , 2003, Acta physiologica Scandinavica.

[54]  Oluf Pedersen,et al.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.

[55]  A. Kalsbeek,et al.  Selective parasympathetic innervation of subcutaneous and intra-abdominal fat--functional implications. , 2002, The Journal of clinical investigation.

[56]  J. Groves,et al.  Part I: Pathogenetic Role of Peroxynitrite in the Development of Diabetes and Diabetic Vascular Complications: Studies With FP15, A Novel Potent Peroxynitrite Decomposition Catalyst , 2002, Molecular medicine.

[57]  A. Vinik,et al.  Chronic exercise is associated with enhanced cutaneous blood flow in type 2 diabetes. , 2002, Journal of diabetes and its complications.

[58]  John E. Hall,et al.  Chronic Cardiovascular and Renal Actions of Leptin: Role of Adrenergic Activity , 2002, Hypertension.

[59]  S. Humphries,et al.  β-Adrenergic regulation of IL-6 release from adipose tissue: In vivo and in vitro studies , 2001 .

[60]  K. Tracey,et al.  Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin , 2000, Nature.

[61]  G. Paolisso,et al.  Plasma leptin concentrations and cardiac autonomic nervous system in healthy subjects with different body weights. , 2000, The Journal of clinical endocrinology and metabolism.

[62]  H. Müller-Gärtner,et al.  Effect of glycaemic control on myocardial sympathetic innervation assessed by [123I]metaiodobenzylguanidine scintigraphy: a 4-year prospective study in IDDM patients , 1998, Diabetologia.

[63]  J. Shepard,et al.  Cardiac arrhythmias during normal sleep and in obstructive sleep apnea syndrome. , 1998, Sleep medicine reviews.

[64]  A Schabmann,et al.  Effects of physical training on heart rate variability in diabetic patients with various degrees of cardiovascular autonomic neuropathy. , 1997, Cardiovascular research.

[65]  F. Gries,et al.  Effects of Treatment With the Antioxidant α-Lipoic Acid on Cardiac Autonomic Neuropathy in NIDDM Patients: A 4-month randomized controlled multicenter trial (DEKAN Study) , 1997, Diabetes Care.

[66]  L. Kuller,et al.  Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study. , 1996, Diabetes research and clinical practice.

[67]  M. Kluger,et al.  Beta-adrenoceptor antagonists suppress elevation in body temperature and increase in plasma IL-6 in rats exposed to open field. , 1996, Neuroendocrinology.

[68]  D. Sutherland,et al.  Neuropathy profile of diabetic patients in a pancreas transplantation program , 1995, Neurology.

[69]  P. Cryer,et al.  Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. , 1993, The Journal of clinical investigation.

[70]  C. Jf,et al.  [Diabetic autonomic neuropathy]. , 1989, Atencion primaria.

[71]  S. Schinner,et al.  Effects of Intensive Glucose Lowering in Type 2 Diabetes , 2009 .

[72]  M. Lenhard,et al.  Continuous positive airway pressure therapy improves cardiovascular autonomic function for persons with sleep-disordered breathing. , 2008, Chest.

[73]  L. Liaudet,et al.  Nitric oxide and peroxynitrite in health and disease. , 2007, Physiological reviews.

[74]  N. Chaturvedi,et al.  Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus , 2004, Diabetologia.

[75]  P A Cleary,et al.  Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). , 2001, The Journal of pediatrics.

[76]  T. Orchard,et al.  Cardiovascular autonomic neuropathy (expiration and inspiration ratio) in type 1 diabetes. Incidence and predictors. , 2000, Journal of diabetes and its complications.

[77]  V. Kadirkamanathan.  The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT) , 1998, Diabetologia.

[78]  F. Gries,et al.  Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. , 1997, Diabetes care.

[79]  W. Rathmann,et al.  Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. The Diacan Multicenter Study Group. , 1993, Diabete & metabolisme.

[80]  W. Rathmann,et al.  Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers , 1993 .